Informed consent is the documented process by which a patient or trial participant voluntarily confirms willingness to receive a treatment or take part in a study after being informed of its purpose, procedures, risks, and alternatives. Within translation and localization, the term usually refers to the informed consent form and related participant materials that ethics committees require in language patients can understand.
In life science translation, informed consent appears primarily in clinical trial documents such as patient information sheets, consent forms, and recruitment brochures. It is handled during ethics committee submissions, site-level adaptation, and protocol amendments. Translators must preserve plain-language explanations of risks, procedures, and data protection while aligning terminology with the approved protocol and local regulatory expectations.
A frequent mistake is rendering consent forms in dense legal or academic language, which makes them hard for patients to understand and may violate plain-language requirements. Conversely, simplifying risk or procedure statements too aggressively can change the clinical meaning. Inconsistent terminology with the protocol or investigator brochure also creates delays and raises ethics committee queries.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →